BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Colmenero J, Rodríguez-Perálvarez M, Salcedo M, Arias-Milla A, Muñoz-Serrano A, Graus J, Nuño J, Gastaca M, Bustamante-Schneider J, Cachero A, Lladó L, Caballero A, Fernández-Yunquera A, Loinaz C, Fernández I, Fondevila C, Navasa M, Iñarrairaegui M, Castells L, Pascual S, Ramírez P, Vinaixa C, González-Dieguez ML, González-Grande R, Hierro L, Nogueras F, Otero A, Álamo JM, Blanco-Fernández G, Fábrega E, García-Pajares F, Montero JL, Tomé S, De la Rosa G, Pons JA. Epidemiological pattern, incidence, and outcomes of COVID-19 in liver transplant patients. J Hepatol 2021;74:148-55. [PMID: 32750442 DOI: 10.1016/j.jhep.2020.07.040] [Cited by in Crossref: 76] [Cited by in F6Publishing: 83] [Article Influence: 38.0] [Reference Citation Analysis]
Number Citing Articles
1 An W, Wang Q, Kim T, Kang J. Clinical characteristics and outcome of coronavirus disease 2019 infection in patients with solid organ transplants: A systematic review and meta-analysis. Journal of Infection and Public Health 2022. [DOI: 10.1016/j.jiph.2022.02.002] [Reference Citation Analysis]
2 Neurath MF. COVID-19: biologic and immunosuppressive therapy in gastroenterology and hepatology. Nat Rev Gastroenterol Hepatol 2021. [PMID: 34188251 DOI: 10.1038/s41575-021-00480-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Dęborska-Materkowska D, Kamińska D. The Immunology of SARS-CoV-2 Infection and Vaccines in Solid Organ Transplant Recipients. Viruses 2021;13:1879. [PMID: 34578460 DOI: 10.3390/v13091879] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Timmermann L, Globke B, Lurje G, Schmelzle M, Schöning W, Öllinger R, Pratschke J, Eberspächer B, Drosten C, Hofmann J, Eurich D. Humoral Immune Response following SARS-CoV-2 Vaccination in Liver Transplant Recipients. Vaccines (Basel) 2021;9:1422. [PMID: 34960168 DOI: 10.3390/vaccines9121422] [Reference Citation Analysis]
5 Russo FP, Izzy M, Rammohan A, Kirchner VA, Di Maira T, Belli LS, Berg T, Berenguer MC, Polak WG. Global impact of the first wave of COVID-19 on liver transplant centers: A multi-society survey (EASL-ESOT/ELITA-ILTS). J Hepatol 2021:S0168-8278(21)02107-3. [PMID: 34653592 DOI: 10.1016/j.jhep.2021.09.041] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Rao A, Puertolas M, Runde J. COVID-19 and Gastrointestinal and Hepatobiliary Diseases. Pediatr Ann 2021;50:e315-9. [PMID: 34398713 DOI: 10.3928/19382359-20210721-02] [Reference Citation Analysis]
7 Yadav DK, Adhikari VP, Ling Q, Liang T. Immunosuppressants in Liver Transplant Recipients With Coronavirus Disease 2019: Capability or Catastrophe?-A Systematic Review and Meta-Analysis. Front Med (Lausanne) 2021;8:756922. [PMID: 34859012 DOI: 10.3389/fmed.2021.756922] [Reference Citation Analysis]
8 Ferreira VH, Marinelli T, Ierullo M, Ku T, Hall VG, Majchrzak-Kita B, Kulasingam V, Humar A, Kumar D. SARS-CoV-2 infection induces greater T-cell responses compared to vaccination in solid organ transplant recipients. J Infect Dis 2021:jiab542. [PMID: 34739078 DOI: 10.1093/infdis/jiab542] [Reference Citation Analysis]
9 Nickerson AM, Sobotka LA, Kelly SG. PRO: Liver Transplantation in the Times of COVID-19: "To Transplant or Not to Transplant". Clin Liver Dis (Hoboken) 2021. [PMID: 34518778 DOI: 10.1002/cld.1131] [Reference Citation Analysis]
10 Tejedor-Tejada J, Fuentes-Valenzuela E, Alonso-Martin C, Almohalla-Alvarez C, Garcia-Pajares F. COVID-19 and short and medium-term outcomes in liver transplant patients: A spanish single-center case series. J Clin Exp Hepatol 2021. [PMID: 34092967 DOI: 10.1016/j.jceh.2021.05.009] [Reference Citation Analysis]
11 Mansoor E, Sclair SS, Cooper GS. Letter to the Editor: Characteristics of Liver Transplant Patients Admitted with COVID-19. Gastroenterology 2021;161:1069-70. [PMID: 34015338 DOI: 10.1053/j.gastro.2021.05.029] [Reference Citation Analysis]
12 Gatti M, Rinaldi M, Bussini L, Bonazzetti C, Pascale R, Pasquini Z, Faní F, Pinho Guedes MN, Azzini AM, Carrara E, Palacios-baena ZR, Caponcello G, Reyna-villasmil E, Tacconelli E, Rodríguez-baño J, Viale P, Giannella M, Caroccia N, Arbizzani F, Giacomini ME, Vatamanu O, Razzaboni E, De Rui ME, Gorska A, Maldonado N, Olivares P, Gutiérrez-campos D, Martín-gutiérrez AB, Palomo V, Serna A. Clinical outcome in solid organ transplant recipients affected by COVID-19 compared to general population: a systematic review and meta-analysis. Clinical Microbiology and Infection 2022. [DOI: 10.1016/j.cmi.2022.02.039] [Reference Citation Analysis]
13 Hutchison AL, Pillai A. The effect of COVID-19 on liver transplantation: impact, practice patterns, therapeutics, and next steps. Curr Opin Organ Transplant 2021;26:339-45. [PMID: 33938470 DOI: 10.1097/MOT.0000000000000883] [Reference Citation Analysis]
14 Cillo U, Vitale A, Volk ML, Frigo AC, Feltracco P, Cattelan A, Brancaccio G, Feltrin G, Angeli P, Burra P, Lonardi S, Trapani S, Cardillo M. Liver Transplantation for T2 Hepatocellular Carcinoma during the COVID-19 Pandemic: A Novel Model Balancing Individual Benefit against Healthcare Resources. Cancers (Basel) 2021;13:1416. [PMID: 33808790 DOI: 10.3390/cancers13061416] [Reference Citation Analysis]
15 Ponziani FR, Aghemo A, Cabibbo G, Masarone M, Montagnese S, Petta S, Russo FP, Lai Q; AISF COVID-19 survey group. Management of liver disease in Italy after one year of the SARS-CoV-2 pandemic: A web-based survey. Liver Int 2021;41:2228-32. [PMID: 34219343 DOI: 10.1111/liv.14998] [Reference Citation Analysis]
16 Nasa P, Alexander G. COVID-19 and the liver: What do we know so far? World J Hepatol 2021; 13(5): 522-532 [PMID: 34131467 DOI: 10.4254/wjh.v13.i5.522] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
17 Gonzalez AJ, Kapila N, Thomas E, Pinna A, Tzakis A, Zervos XB. Managing liver transplantation during the COVID-19 pandemic: A survey among transplant centers in the Southeast United States. World J Hepatol 2021; 13(12): 2161-2167 [DOI: 10.4254/wjh.v13.i12.2161] [Reference Citation Analysis]
18 Elnaggar M, Abomhya A, Elkhattib I, Dawoud N, Doshi R. COVID-19 and liver diseases, what we know so far. World J Clin Cases 2022; 10(13): 3969-3980 [DOI: 10.12998/wjcc.v10.i13.3969] [Reference Citation Analysis]
19 Heldman MR, Kates OS. COVID-19 in Solid Organ Transplant Recipients: a Review of the Current Literature. Curr Treat Options Infect Dis 2021;:1-16. [PMID: 34220357 DOI: 10.1007/s40506-021-00249-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
20 Berg N, Ilonze O, Bajpai V, Guglin M, Rao R. Acute Biventricular Heart Failure After COVID-19 Infection in an Orthotropic Heart Transplant Patient: A Case Report. Transplant Proc 2021;53:1224-6. [PMID: 33892935 DOI: 10.1016/j.transproceed.2021.03.013] [Reference Citation Analysis]
21 Piedade J, Pereira G. COVID-19 in liver transplant recipients. Journal of Liver Transplantation 2021;3:100026. [DOI: 10.1016/j.liver.2021.100026] [Reference Citation Analysis]
22 Rodríguez-Perálvarez M, Colmenero J, Salcedo M; Spanish Society of Liver Transplantation (SETH). Reply to: "Age and comorbidity are central to the risk of death from COVID-19 in liver transplant recipients". J Hepatol 2021;75:228-9. [PMID: 33862040 DOI: 10.1016/j.jhep.2021.04.005] [Reference Citation Analysis]
23 Webb GJ, Moon AM, Barnes E, Barritt AS 4th, Marjot T. Age and comorbidity are central to the risk of death from COVID-19 in liver transplant recipients. J Hepatol 2021;75:226-8. [PMID: 33556419 DOI: 10.1016/j.jhep.2021.01.036] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
24 Assa A, Benninga MA, Borrelli O, Broekaert I, de Carpi JM, Saccomani MD, Dolinsek J, Mas E, Miele E, Thomson M, Tzivinikos C; Gastrointestinal Committee of ESPGHAN. Gastrointestinal Perspective of Coronavirus Disease 2019 in Children-An Updated Review. J Pediatr Gastroenterol Nutr 2021;73:299-305. [PMID: 34117195 DOI: 10.1097/MPG.0000000000003204] [Reference Citation Analysis]
25 McGrowder DA, Miller F, Anderson Cross M, Anderson-Jackson L, Bryan S, Dilworth L. Abnormal Liver Biochemistry Tests and Acute Liver Injury in COVID-19 Patients: Current Evidence and Potential Pathogenesis. Diseases 2021;9:50. [PMID: 34287285 DOI: 10.3390/diseases9030050] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
26 Barzegar M, Mirmosayyeb O, Ebrahimi N, Bagherieh S, Afshari-safavi A, Hosseinabadi AM, Shaygannejad V, Asgari N. COVID-19 susceptibility and outcomes among patients with neuromyelitis optica spectrum disorder (NMOSD): A systematic review and meta-analysis. Multiple Sclerosis and Related Disorders 2021. [DOI: 10.1016/j.msard.2021.103359] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Caballero-Marcos A, Salcedo M, Alonso-Fernández R, Rodríguez-Perálvarez M, Olmedo M, Graus Morales J, Cuervas-Mons V, Cachero A, Loinaz-Segurola C, Iñarrairaegui M, Castells L, Pascual S, Vinaixa-Aunés C, González-Grande R, Otero A, Tomé S, Tejedor-Tejada J, Álamo-Martínez JM, González-Diéguez L, Nogueras-Lopez F, Blanco-Fernández G, Muñoz-Bartolo G, Bustamante FJ, Fábrega E, Romero-Cristóbal M, Martin-Mateos R, Del Rio-Izquierdo J, Arias-Milla A, Calatayud L, Marcacuzco-Quinto AA, Fernández-Alonso V, Gómez-Gavara C, Colmenero J, Muñoz P, Pons JA; Spanish Society of Liver Transplantation (SETH). Changes in humoral immune response after SARS-CoV-2 infection in liver transplant recipients compared to immunocompetent patients. Am J Transplant 2021;21:2876-84. [PMID: 33835707 DOI: 10.1111/ajt.16599] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
28 Merli M, Pasulo L, Perricone G, Travi G, Rossotti R, Colombo VG, De Carlis R, Chiappetta S, Moioli MC, Minetti E, Frigerio M, De Carlis LG, Belli L, Fagiuoli S, Puoti M. Impact of immunosuppressive therapy on the severity of COVID-19 in solid organ transplant recipients. J Infect 2021;82:414-51. [PMID: 33127455 DOI: 10.1016/j.jinf.2020.10.024] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
29 Mallet V, Beeker N, Bouam S, Sogni P, Pol S; Demosthenes research group. Prognosis of French COVID-19 patients with chronic liver disease: A national retrospective cohort study for 2020. J Hepatol 2021;75:848-55. [PMID: 33992699 DOI: 10.1016/j.jhep.2021.04.052] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
30 Choudhary NS, Dhampalwar S, Saraf N, Soin AS. Outcomes of COVID-19 in Patients with Cirrhosis or Liver Transplantation. J Clin Exp Hepatol 2021. [PMID: 33994708 DOI: 10.1016/j.jceh.2021.05.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
31 Spini A, Giudice V, Brancaleone V, Morgese MG, De Francia S, Filippelli A, Ruggieri A, Ziche M, Ortona E, Cignarella A, Trabace L. Sex-tailored pharmacology and COVID-19: Next steps towards appropriateness and health equity. Pharmacol Res 2021;173:105848. [PMID: 34454035 DOI: 10.1016/j.phrs.2021.105848] [Reference Citation Analysis]
32 Jaduan SS, Singh SA, Madan K, Gupta S. SARS-CoV-2 infection in Liver Transplant recipients - Immunosuppression is the silver lining? J Clin Exp Hepatol 2021. [PMID: 34305351 DOI: 10.1016/j.jceh.2021.07.005] [Reference Citation Analysis]
33 Madhu D, Sharma S, Agarwal A, Saraya A. Special Considerations in the Management of Autoimmune Hepatitis in COVID-19 Hotspots: A Review. J Clin Transl Hepatol 2021;9:568-75. [PMID: 34447687 DOI: 10.14218/JCTH.2021.00001] [Reference Citation Analysis]
34 Mikolasevic I, Bozic D, Pavić T, Ruzic A, Hauser G, Radic M, Radic-Kristo D, Razov-Radas M, Puljiz Z, Milic S. Liver disease in the era of COVID-19: Is the worst yet to come? World J Gastroenterol 2021; 27(36): 6039-6052 [PMID: 34629818 DOI: 10.3748/wjg.v27.i36.6039] [Reference Citation Analysis]
35 Testino G, Vignoli T, Patussi V, Allosio P, Amendola MF, Aricò S, Baselice A, Balbinot P, Campanile V, Fanucchi T, Greco G, Macciò L, Meneguzzi C, Mioni D, Palmieri VO, Parisi M, Renzetti D, Rossin R, Gandin C, Bottaro LC, Bernardi M, Addolorato G, Lungaro L, Zoli G, Scafato E, Caputo F. Alcohol-Related Liver Disease in the Covid-19 Era: Position Paper of the Italian Society on Alcohol (SIA). Dig Dis Sci 2021. [PMID: 34142284 DOI: 10.1007/s10620-021-07006-1] [Reference Citation Analysis]
36 Vinson AJ, Dai R, Agarwal G, Anzalone AJ, Lee SB, French E, Olex AL, Madhira V, Mannon RB; National COVID Cohort Collaborative (N3C) Consortium. Sex and organ-specific risk of major adverse renal or cardiac events in solid organ transplant recipients with COVID-19. Am J Transplant 2021. [PMID: 34637599 DOI: 10.1111/ajt.16865] [Reference Citation Analysis]
37 Du M, Yang DS, Liu M, Liu J. COVID-19 and Liver dysfunction: Epidemiology, Association and Potential Mechanisms. Clin Res Hepatol Gastroenterol 2021;:101793. [PMID: 34428501 DOI: 10.1016/j.clinre.2021.101793] [Reference Citation Analysis]
38 Loinaz-Segurola C, Marcacuzco-Quinto A, Fernández-Ruiz M. Coronavirus disease 2019 in liver transplant patients: Clinical and therapeutic aspects. World J Hepatol 2021; 13(10): 1299-1315 [PMID: 34786167 DOI: 10.4254/wjh.v13.i10.1299] [Reference Citation Analysis]
39 Zecher BF, Buescher G, Willemse J, Walmsley M, Taylor A, Leburgue A, Schramm C, Lohse AW, Sebode M. Prevalence of COVID-19 in patients with autoimmune liver disease in Europe: A patient-oriented online survey. United European Gastroenterol J 2021. [PMID: 34105883 DOI: 10.1002/ueg2.12100] [Reference Citation Analysis]
40 Saviano A, Wrensch F, Ghany MG, Baumert TF. Liver disease and COVID-19: from Pathogenesis to Clinical Care. Hepatology. 2020;. [PMID: 33332624 DOI: 10.1002/hep.31684] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
41 Kirchner T, Jaeckel E, Falk CS, Eiz-Vesper B, Taubert R. SARS-CoV-2-specific immunity in immunosuppressed COVID-19 convalescents with autoimmune hepatitis. J Hepatol 2021;75:1506-9. [PMID: 34284030 DOI: 10.1016/j.jhep.2021.07.012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
42 Belli LS, Conti S, Polak W. Reply. Gastroenterology 2021;161:731-2. [PMID: 33891952 DOI: 10.1053/j.gastro.2021.04.033] [Reference Citation Analysis]
43 Laracy JC, Miko BA, Pereira MR. The solid organ transplant recipient with SARS-CoV-2 infection. Curr Opin Organ Transplant 2021;26:412-8. [PMID: 34074938 DOI: 10.1097/MOT.0000000000000888] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
44 Fernández-Ruiz M, Olea B, Almendro-Vázquez P, Giménez E, Marcacuzco A, San Juan R, Justo I, Calvo-Pulido J, García-Sesma Á, Manrique A, Caso O, Cambra F, Talayero P, López-Medrano F, Remigia MJ, Ruiz-Merlo T, Parra P, Paz-Artal E, Jiménez C, Loinaz C, Navarro D, Laguna-Goya R, Aguado JM. T cell-mediated response to SARS-CoV-2 in liver transplant recipients with prior COVID-19. Am J Transplant 2021;21:2785-94. [PMID: 34092033 DOI: 10.1111/ajt.16708] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
45 Kidson KM, Park J, Charles MK, Omar M, Krajden M, Wright AJ, Hussaini T, Kim PTW, Chung SW, Yoshida EM. Successful Liver Transplantation in a Patient With Acute COVID-19 Infection and Acute Liver Failure: A Case Report. Transplant Direct 2021;7:e747. [PMID: 34476292 DOI: 10.1097/TXD.0000000000001210] [Reference Citation Analysis]
46 Kullar R, Patel AP, Saab S. COVID-19 in Liver Transplant Recipients. J Clin Transl Hepatol 2021;9:545-50. [PMID: 34447684 DOI: 10.14218/JCTH.2020.00098] [Reference Citation Analysis]
47 Signorello A, Lenci I, Milana M, Grassi G, Baiocchi L. COVID-19 in normal, diseased and transplanted liver. World J Gastroenterol 2021; 27(20): 2576-2585 [PMID: 34092976 DOI: 10.3748/wjg.v27.i20.2576] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
48 Kuroda N. Epilepsy and COVID-19: Updated evidence and narrative review. Epilepsy Behav 2021;116:107785. [PMID: 33515934 DOI: 10.1016/j.yebeh.2021.107785] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
49 Arora H, Boothby-Shoemaker W, Braunberger T, Lim HW, Veenstra J. Safety of conventional immunosuppressive therapies for patients with dermatological conditions and coronavirus disease 2019: A review of current evidence. J Dermatol 2021. [PMID: 34962304 DOI: 10.1111/1346-8138.16182] [Reference Citation Analysis]
50 Nabil A, Elshemy MM, Uto K, Soliman R, Hassan AA, Shiha G, Ebara M. Coronavirus (SARS-CoV-2) in gastroenterology and its current epidemiological situation: An updated review until January 2021. EXCLI J 2021;20:366-85. [PMID: 33746667 DOI: 10.17179/excli2021-3417] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
51 Alukal JJ, Naqvi HA, Thuluvath PJ. Vaccination in Chronic Liver Disease: An Update. J Clin Exp Hepatol 2021. [PMID: 34975241 DOI: 10.1016/j.jceh.2021.12.003] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
52 Scharringa S, Hoffman T, van Kessel DA, Rijkers GT. Vaccination and their importance for lung transplant recipients in a COVID-19 world. Expert Rev Clin Pharmacol 2021;:1-13. [PMID: 34328054 DOI: 10.1080/17512433.2021.1961577] [Reference Citation Analysis]
53 Altunisik Toplu S, Bayindir Y, Yilmaz S, Yalçınsoy M, Otlu B, Kose A, Sahin TT, Akbulut S, Isik B, Başkiran A, Koc C. Short-term experiences of a liver transplant centre before and after the COVID-19 pandemic. Int J Clin Pract 2021;:e14668. [PMID: 34327793 DOI: 10.1111/ijcp.14668] [Reference Citation Analysis]
54 Elhence A, Vaishnav M, Biswas S, Anand A, Gunjan D, Kedia S, Mahapatra SJ, Nayak B, Sheikh S, Soni KD, Trikha A, Goel A, Shalimar. Predictors of in-hospital outcomes in patients with Cirrhosis and Coronavirus disease-2019. J Clin Exp Hepatol 2021. [PMID: 34728983 DOI: 10.1016/j.jceh.2021.10.014] [Reference Citation Analysis]
55 Dale M, Sogawa H, Seyedsaadat SM, Wolf DC, Bodin R, Partiula B, Nog R, Latifi R, John D, Veillette G, Diflo T, Nishida S. Successful Management of COVID-19 Infection in 2 Early Post-Liver Transplant Recipients. Transplant Proc 2021;53:1175-9. [PMID: 33888342 DOI: 10.1016/j.transproceed.2021.03.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
56 Heldman MR, Kates OS, Fisher CE, Limaye AP. Immunosuppression in solid organ transplant recipients with Covid-19: More data, but still complicated. Transpl Infect Dis 2021;23:e13650. [PMID: 34325492 DOI: 10.1111/tid.13650] [Reference Citation Analysis]
57 Frankel AE, Yip WC, Naik E, Hasselbalch HC. Response to pegylated interferon in a COVID-19 positive male with metastatic jejunal neuroendocrine tumor treated with everolimus. Clin Case Rep 2021;9:e04218. [PMID: 34136234 DOI: 10.1002/ccr3.4218] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
58 Ekpanyapong S, Bunchorntavakul C, Reddy KR. COVID-19 and the Liver: Lessons Learnt from the EAST and the WEST, A Year Later. J Viral Hepat 2021. [PMID: 34352133 DOI: 10.1111/jvh.13590] [Reference Citation Analysis]
59 Kates OS, Rakita RM, Lease ED, Fisher CE, Limaye AP. Reply to Authors. Clin Infect Dis 2020:ciaa1633. [PMID: 33104183 DOI: 10.1093/cid/ciaa1633] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
60 Neuman MG, Seitz HK, Teschke R, Malnick S, Johnson-davis KL, Cohen LB, German A, Hohmann N, Moreira B, Moussa G, Opris M. Molecular, Viral and Clinical Features of Alcohol- and Non-Alcohol-Induced Liver Injury. CIMB 2022;44:1294-315. [DOI: 10.3390/cimb44030087] [Reference Citation Analysis]
61 Muhammad H, Zaffar D, Tehreem A. Letter to the Editor: Living Donor Liver Transplantation During the COVID-19 Pandemic: An Evolving Challenge. J Gastrointest Surg 2021;25:3031. [PMID: 34506033 DOI: 10.1007/s11605-021-05142-7] [Reference Citation Analysis]
62 Quante M, Brake L, Tolios A, Della Penna A, Steidle C, Gruendl M, Grishina A, Haeberle H, Guthoff M, Tullius SG, Königsrainer A, Nadalin S, Löffler MW. SARS-CoV-2 in Solid Organ Transplant Recipients: A Structured Review of 2020. Transplant Proc 2021;53:2421-34. [PMID: 34551880 DOI: 10.1016/j.transproceed.2021.08.019] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
63 Regmi P, Liu F, Li FY. Characteristics of Liver Transplant Patients Infected with COVID-19. Gastroenterology 2021;161:1068-1069.e1. [PMID: 33465372 DOI: 10.1053/j.gastro.2021.01.032] [Reference Citation Analysis]
64 Jefremow A, Neurath MF. SARS-CoV-2 Virus Manifestations in the Gastrointestinal Tract: Therapeutic Implications. Visc Med 2021;37:63-9. [PMID: 33693046 DOI: 10.1159/000513180] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
65 Samidoust P, Esmaeili Delshad MS, Navid Talemi R, Mojtahedi K, Samidoust A, Jahangiri S, Ashoobi MT. Incidence, characteristics, and outcome of COVID-19 in patients on liver transplant program: a retrospective study in the north of Iran. New Microbes New Infect 2021;44:100935. [PMID: 34493955 DOI: 10.1016/j.nmni.2021.100935] [Reference Citation Analysis]
66 Polak WG, Fondevila C, Karam V, Adam R, Belli LS, Duvoux C; for European Liver, Intestine Transplant Association (ELITA), the COVID-19 ELITA Study Group. Reply to Rodriguez-Peralvarez et al. Transpl Int 2020;33:1825-6. [PMID: 33037657 DOI: 10.1111/tri.13765] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
67 Cho JY, Lee YS, Kim SS, Song DS, Lee JH, Kim JH. Update on liver disease management during the pandemic of coronavirus disease 2019 (COVID-19): 2021 KASL guideline. Clin Mol Hepatol 2021;27:515-23. [PMID: 34530524 DOI: 10.3350/cmh.2021.0293] [Reference Citation Analysis]
68 Visco-comandini U, Castilletti C, Lionetti R, Meschi S, Montalbano M, Rianda A, Taibi C, Sorace C, Guglielmo N, Piccolo P, Paci P, Ettorre GM, Gianpiero D. High prevalence of asymptomatic SARS-CoV-2 infection in a cohort of liver transplant recipients in central Italy. Journal of Liver Transplantation 2022;5:100064. [DOI: 10.1016/j.liver.2021.100064] [Reference Citation Analysis]
69 De Carlis R, Vella I, Incarbone N, Centonze L, Buscemi V, Lauterio A, De Carlis L. Impact of the COVID-19 pandemic on liver donation and transplantation: A review of the literature. World J Gastroenterol 2021; 27(10): 928-938 [PMID: 33776364 DOI: 10.3748/wjg.v27.i10.928] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
70 Concas G, Barone M, Francavilla R, Cristofori F, Dargenio VN, Giorgio R, Dargenio C, Fanos V, Marcialis MA. Twelve Months with COVID-19: What Gastroenterologists Need to Know. Dig Dis Sci 2021. [PMID: 34333726 DOI: 10.1007/s10620-021-07158-0] [Reference Citation Analysis]
71 Jakharia N, Subramanian A, Shapiro AE. COVID-19 in the Immunocompromised Host, including People with HIV. Infectious Disease Clinics of North America 2022. [DOI: 10.1016/j.idc.2022.01.006] [Reference Citation Analysis]
72 Abolghasemi S, Zolfaghari F, Naeimipoor M, Azhdari Tehrani H, Hakamifard A. COVID-19 reinfection or reactivation in a renal transplant patient. Clin Case Rep 2021;9:e04672. [PMID: 34430026 DOI: 10.1002/ccr3.4672] [Reference Citation Analysis]
73 Ng AC. Stick to Milan: Infeasibility of the Brazil-Milan Criteria in recommending patients with hepatocellular carcinoma for liver transplantation. Ann Hepatol 2021;25:100537. [PMID: 34547478 DOI: 10.1016/j.aohep.2021.100537] [Reference Citation Analysis]
74 Freitas AF, Pugliese RPS, Feier F, Miura IK, Danesi VLB, Oliveira EN, Hirschfeld APM, Borges CBV, Lobato JV, Porta G, Seda-neto J, Fonseca EA. Impact of COVID-19 Infection on Children and Adolescents after Liver Transplantation in a Latin American Reference Center. Microorganisms 2022;10:1030. [DOI: 10.3390/microorganisms10051030] [Reference Citation Analysis]
75 Hu X, Sun L, Guo Z, Wu C, Yu X, Li J. Management of COVID-19 Patients with Chronic Liver Diseases and Liver Transplants. Ann Hepatol 2021;:100653. [PMID: 34929350 DOI: 10.1016/j.aohep.2021.100653] [Reference Citation Analysis]
76 Webb GJ, Marjot T, Barnes E, Barritt AS 4th, Moon AM. COVID-19 and liver transplantation: the jury is still out - Authors' reply. Lancet Gastroenterol Hepatol 2021;6:11. [PMID: 33137285 DOI: 10.1016/S2468-1253(20)30337-X] [Reference Citation Analysis]
77 Weiss MJ, Hornby L, Foroutan F, Belga S, Bernier S, Bhat M, Buchan CA, Gagnon M, Hardman G, Ibrahim M, Luo C, Luong ML, Mainra R, Manara AR, Sapir-Pichhadze R, Shalhoub S, Shaver T, Singh JM, Srinathan S, Thomas I, Wilson LC, Wilson TM, Wright A, Mah A. Clinical Practice Guideline for Solid Organ Donation and Transplantation During the COVID-19 Pandemic. Transplant Direct 2021;7:e755. [PMID: 34514110 DOI: 10.1097/TXD.0000000000001199] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
78 Gato S, Lucena-Valera A, Muñoz-Hernández R, Sousa JM, Romero-Gómez M, Ampuero J. Impact of COVID-19 on liver disease: From the experimental to the clinic perspective. World J Virol 2021; 10(6): 301-311 [PMID: 34909404 DOI: 10.5501/wjv.v10.i6.301] [Reference Citation Analysis]
79 Philips CA, Rela M, Soin AS, Gupta S, Surendran S, Augustine P. Critical Update on the Diagnosis and Management of COVID-19 in Advanced Cirrhosis and Liver Transplant Recipients. J Clin Transl Hepatol 2021;9:947-59. [PMID: 34966658 DOI: 10.14218/JCTH.2021.00228] [Reference Citation Analysis]
80 Pearson MM, Limaye AP, Biggins SW. Tacrolimus: Unlikely Harmful and Perhaps Helpful in Liver Transplant Recipients with COVID-19. Gastroenterology. 2021;160:1012-1013. [PMID: 33387518 DOI: 10.1053/j.gastro.2020.12.050] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
81 Terziroli Beretta-Piccoli B, Lleo A. Is immunosuppression truly associated with worse outcomes in autoimmune hepatitis patients with COVID-19? Liver Int 2022;42:274-6. [PMID: 35092335 DOI: 10.1111/liv.15138] [Reference Citation Analysis]
82 Di Giorgio A, Hartleif S, Warner S, Kelly D. COVID-19 in Children With Liver Disease. Front Pediatr 2021;9:616381. [PMID: 33777864 DOI: 10.3389/fped.2021.616381] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
83 Abdullatif H, Elakel W, Baroudy S, El-karaksy H, Mogahed EA. Covid-19 pandemic in egyptian children with liver diseases: incidence and impact on health care service delivery in a low/middle income country. Arab Journal of Gastroenterology 2022. [DOI: 10.1016/j.ajg.2022.01.002] [Reference Citation Analysis]
84 Spearman CW, Aghemo A, Valenti L, Sonderup MW. COVID-19 and the liver: A 2021 update. Liver Int 2021;41:1988-98. [PMID: 34152690 DOI: 10.1111/liv.14984] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
85 Abu-Rub LI, Abdelrahman HA, Johar AA, Alhussain HA, Hadi HA, Eltai NO. Antibiotics Prescribing in Intensive Care Settings during the COVID-19 Era: A Systematic Review. Antibiotics (Basel) 2021;10:935. [PMID: 34438985 DOI: 10.3390/antibiotics10080935] [Reference Citation Analysis]
86 Nasa P, Alexander G. COVID-19 and the liver: What do we know so far? World J Hepatol 2021;13:522-32. [PMID: 34131467 DOI: 10.4254/wjh.v13.i5.522] [Reference Citation Analysis]
87 Kakos CD, Ziogas IA, Tsoulfas G. Pediatric transplantation during the COVID-19 pandemic. World J Transplant 2022; 12(5): 88-99 [DOI: 10.5500/wjt.v12.i5.88] [Reference Citation Analysis]
88 Efe C, Lammert C, Taşçılar K, Dhanasekaran R, Ebik B, Higuera-de la Tijera F, Calışkan AR, Peralta M, Gerussi A, Massoumi H, Catana AM, Purnak T, Rigamonti C, Aldana AJG, Khakoo N, Nazal L, Frager S, Demir N, Irak K, Melekoğlu-Ellik Z, Kacmaz H, Balaban Y, Atay K, Eren F, Alvares-da-Silva MR, Cristoferi L, Urzua Á, Eşkazan T, Magro B, Snijders R, Barutçu S, Lytvyak E, Zazueta GM, Demirezer-Bolat A, Aydın M, Heurgue-Berlot A, De Martin E, Ekin N, Yıldırım S, Yavuz A, Bıyık M, Narro GC, Kıyıcı M, Akyıldız M, Kahramanoğlu-Aksoy E, Vincent M, Carr RM, Günşar F, Reyes EC, Harputluoğlu M, Aloman C, Gatselis NK, Üstündağ Y, Brahm J, Vargas NCE, Güzelbulut F, Garcia SR, Aguirre J, Anders M, Ratusnu N, Hatemi I, Mendizabal M, Floreani A, Fagiuoli S, Silva M, Idilman R, Satapathy SK, Silveira M, Drenth JPH, Dalekos GN, N Assis D, Björnsson E, Boyer JL, Yoshida EM, Invernizzi P, Levy C, Montano-Loza AJ, Schiano TD, Ridruejo E, Wahlin S. Effects of immunosuppressive drugs on COVID-19 severity in patients with autoimmune hepatitis. Liver Int 2021. [PMID: 34846800 DOI: 10.1111/liv.15121] [Reference Citation Analysis]
89 Gupta M, Manek G, Dombrowski K, Maiwall R. Newer developments in viral hepatitis: Looking beyond hepatotropic viruses. World J Meta-Anal 2021; 9(6): 522-542 [DOI: 10.13105/wjma.v9.i6.522] [Reference Citation Analysis]
90 Almas T, Ehtesham M, Khedro T, Haadi A, Nabeel AR, Hussain S, Alsufyani R, Al-Awaid AH, Sclair S, Mansoor E. The many faces of coronavirus disease 2019: COVID-19 and the liver. Ann Med Surg (Lond) 2021;64:102224. [PMID: 33747505 DOI: 10.1016/j.amsu.2021.102224] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
91 Rodríguez‐perálvarez M, Salcedo M, Colmenero J, Pons JA; On behalf the Spanish Society of Liver Transplantation (SETH). Increased incidence of COVID‐19 among liver transplant patients in Europe. Transpl Int 2020;33:1823-4. [DOI: 10.1111/tri.13729] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
92 Toniutto P, Falleti E, Cmet S, Cussigh A, Veneto L, Bitetto D, Fornasiere E, Fumolo E, Fabris C, Sartor A, Peressutti R, Curcio F, Regattin L, Grillone L. Past COVID-19 and immunosuppressive regimens affect the long-term response to anti-SARS-CoV-2 vaccination in liver transplant recipients. Journal of Hepatology 2022. [DOI: 10.1016/j.jhep.2022.02.015] [Reference Citation Analysis]
93 Yin S, Wang X, Song T. Tacrolimus Use and COVID-19 Infection in Patients After Solid Organ Transplantation. Gastroenterology 2021;161:728-730.e1. [PMID: 33539863 DOI: 10.1053/j.gastro.2021.01.223] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
94 Jayant K, Reccia I, Virdis F, Pyda JS, Bachul PJ, di Sabato D, Barth RN, Fung J, Baker T, Witkowski P. COVID-19 in hospitalized liver transplant recipients: An early systematic review and meta-analysis. Clin Transplant 2021;35:e14246. [PMID: 33555058 DOI: 10.1111/ctr.14246] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
95 Elhence A, Vaishnav M, Biswas S, Chauhan A, Anand A, Shalimar. Coronavirus Disease-2019 (COVID-19) and the Liver. J Clin Transl Hepatol 2021;9:247-55. [PMID: 34007807 DOI: 10.14218/JCTH.2021.00006] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
96 Taylor R 3rd, Mallon D. COVID-19 and Pediatric Gastroenterology. Pediatr Clin North Am 2021;68:1157-69. [PMID: 34736582 DOI: 10.1016/j.pcl.2021.07.003] [Reference Citation Analysis]
97 Marjot T, Webb GJ, Barritt AS 4th, Moon AM, Stamataki Z, Wong VW, Barnes E. COVID-19 and liver disease: mechanistic and clinical perspectives. Nat Rev Gastroenterol Hepatol 2021;18:348-64. [PMID: 33692570 DOI: 10.1038/s41575-021-00426-4] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 27.0] [Reference Citation Analysis]
98 Yohanathan L, Campioli CC, Mousa OY, Watt K, Friedman DZP, Shah V, Ramkissoon R, Hines AS, Kamath PS, Razonable RR, Badley AD, DeMartino ES, Joyner MJ, Graham R, Vergidis P, Simonetto DA, Sanchez W, Taner T, Heimbach JK, Beam E, Leise MD. Liver transplantation for acute liver failure in a SARS-CoV-2 PCR-positive patient. Am J Transplant 2021;21:2890-4. [PMID: 33792185 DOI: 10.1111/ajt.16582] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
99 Moon AM, Webb GJ, García-Juárez I, Kulkarni AV, Adali G, Wong DK, Lusina B, Dalekos GN, Masson S, Shore BM, Barnes E, Barritt AS 4th, Marjot T. SARS-CoV-2 Infections Among Patients With Liver Disease and Liver Transplantation Who Received COVID-19 Vaccination. Hepatol Commun 2021. [PMID: 34708575 DOI: 10.1002/hep4.1853] [Reference Citation Analysis]
100 Yuksel M, Akturk H, Mizikoglu O, Toroslu E, Arikan C. A single-center report of COVID-19 disease course and management in liver transplanted pediatric patients. Pediatr Transplant 2021;:e14061. [PMID: 34076953 DOI: 10.1111/petr.14061] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
101 Kulkarni AV, Tevethia HV, Premkumar M, Arab JP, Candia R, Kumar K, Kumar P, Sharma M, Rao PN, Reddy DN. Impact of COVID-19 on liver transplant recipients-A systematic review and meta-analysis. EClinicalMedicine 2021;38:101025. [PMID: 34278287 DOI: 10.1016/j.eclinm.2021.101025] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
102 Rabiee A, Sadowski B, Adeniji N, Perumalswami PV, Nguyen V, Moghe A, Latt NL, Kumar S, Aloman C, Catana AM, Bloom PP, Chavin KD, Carr RM, Dunn W, Chen VL, Aby ES, Debes JD, Dhanasekaran R;  COLD Consortium. Liver Injury in Liver Transplant Recipients With Coronavirus Disease 2019 (COVID-19): U.S. Multicenter Experience. Hepatology. 2020;72:1900-1911. [PMID: 32964510 DOI: 10.1002/hep.31574] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 13.0] [Reference Citation Analysis]
103 Phipps MM, Verna EC. Coronavirus Disease 2019 and Liver Transplantation: Lessons from the First Year of the Pandemic. Liver Transpl 2021;27:1312-25. [PMID: 34096188 DOI: 10.1002/lt.26194] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
104 Skladany L, Koller T, Adamcova Selcanova S, Vnencakova J, Jancekova D, Durajova V, Laffers L, Svac J, Janickova K, Palkovič M, Kohout P, Golubnitschaja O. Challenging management of severe chronic disorders in acute pandemic situation: Chronic liver disease under COVID-19 pandemic as the proof-of-principle model to orchestrate the measures in 3PM context. EPMA J 2021;:1-14. [PMID: 33680218 DOI: 10.1007/s13167-021-00231-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
105 Campos-Varela I, Len O, Villagrasa A, Márquez-Algaba E, Esperalba J, Dopazo C, Los-Arcos I, Antón A, Castells L. Low seroprevalence of SARS-CoV-2 antibodies in a liver transplant cohort. Transpl Int 2021. [PMID: 34121244 DOI: 10.1111/tri.13946] [Reference Citation Analysis]
106 Kose A, Toplu SA, Yalcinsoy M, Yakupogullari Y, Otlu B, Otan E, Aydin C, Yilmaz S, Bayindir Y. Clinical Characteristics and Outcomes of Liver Transplantation Recipients With COVID-19 Pneumonia. Transplant Proc 2021:S0041-1345(21)00448-6. [PMID: 34261580 DOI: 10.1016/j.transproceed.2021.06.027] [Reference Citation Analysis]
107 Alfishawy M, Nso N, Nassar M, Ariyaratnam J, Bhuiyan S, Siddiqui RS, Li M, Chung H, Al Balakosy A, Alqassieh A, Fülöp T, Rizzo V, Daoud A, Soliman KM. Liver transplantation during global COVID-19 pandemic. World J Clin Cases 2021; 9(23): 6608-6623 [PMID: 34447809 DOI: 10.12998/wjcc.v9.i23.6608] [Reference Citation Analysis]
108 Prieto Santamaría L, Díaz Uzquiano M, Ugarte Carro E, Ortiz-Roldán N, Pérez Gallardo Y, Rodríguez-González A. Integrating heterogeneous data to facilitate COVID-19 drug repurposing. Drug Discov Today 2021:S1359-6446(21)00438-4. [PMID: 34666181 DOI: 10.1016/j.drudis.2021.10.002] [Reference Citation Analysis]
109 Patel P, Pillai A. Liver Transplantation Services During the Time of COVID-19. J Clin Transl Hepatol 2021;9:587-91. [PMID: 34447689 DOI: 10.14218/JCTH.2021.00095] [Reference Citation Analysis]
110 Tacke F, Cornberg M, Sterneck M, Trebicka J, Settmacher U, Bechstein WO, Berg T; Deutsche Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS), vertreten durch Frank Tacke, Markus Cornberg, Martina Sterneck, Jonel Trebicka, Thomas Berg., Deutsche Gesellschaft für Allgemein- und Viszeralchirurgie (DGAV), vertreten durch Wolf Bechstein., Deutsche Transplantationsgesellschaft (DTG), vertreten durch Utz Settmacher., Die Leitlinie wird von der Deutschen Gesellschaft für Pneumologie (DGP) unterstützt. S1-Leitlinie zur Versorgung von Lebertransplantierten während der COVID-19-Pandemie – AWMF-Register Nr. 021-031 – Stand: 07.01.21. Z Gastroenterol 2021;59:345-59. [PMID: 33845500 DOI: 10.1055/a-1372-5595] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
111 Stainer A, Amati F, Suigo G, Simonetta E, Gramegna A, Voza A, Aliberti S. COVID-19 in Immunocompromised Patients: A Systematic Review. Semin Respir Crit Care Med 2021;42:839-58. [PMID: 34918325 DOI: 10.1055/s-0041-1740110] [Reference Citation Analysis]
112 Goldman JD, Robinson PC, Uldrick TS, Ljungman P. COVID-19 in immunocompromised populations: implications for prognosis and repurposing of immunotherapies. J Immunother Cancer 2021;9:e002630. [PMID: 34117116 DOI: 10.1136/jitc-2021-002630] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
113 Yılmaz EA, Özdemir Ö. Solid organ transplantations and COVID-19 disease. World J Transplant 2021; 11(12): 503-511 [DOI: 10.5500/wjt.v11.i12.503] [Reference Citation Analysis]
114 Sarmiento-Monroy JC, Espinosa G, Londoño MC, Meira F, Caballol B, Llufriu S, Carrasco JL, Moll-Udina A, Quintana LF, Giavedoni P, Ramírez J, Inciarte-Mundo J, Solana E, Blanco Y, Martinez-Hernandez E, Sepúlveda M, Llorenç V, Prieto-González S, Espígol-Frigolé G, Milisenda JC, Cid MC, Mascaró JM Jr, Blanco I, Barberá JA, Sibila O, Gratacos-Ginès J, Adán A, Agustí A, Sanmartí R, Panés J, Cervera R, Vila J, Soriano A, Gómez-Puerta JA; Immunocovid Clinic. A multidisciplinary registry of patients with autoimmune and immune-mediated diseases with symptomatic COVID-19 from a single center. J Autoimmun 2021;117:102580. [PMID: 33338707 DOI: 10.1016/j.jaut.2020.102580] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
115 Nacif LS, Fernandes MR, Waisberg DR, Pinheiro RS, Rocha-santos V, Galvão F, Andraus W, Carneiro-d'albuquerque LA. Liver transplant after SARS-CoV-2 infection: a systematic review. Clinics 2022. [DOI: 10.1016/j.clinsp.2022.100042] [Reference Citation Analysis]
116 Moloney PB, Delanty N. Stick or twist: Everolimus for seizures in tuberous sclerosis complex during the COVID-19 pandemic. Seizure 2021;91:271-2. [PMID: 34252878 DOI: 10.1016/j.seizure.2021.06.035] [Reference Citation Analysis]
117 Magro F, Nuzzo A, Abreu C, Libânio D, Rodriguez-Lago I, Pawlak K, Hollenbach M, Brouwer WP, Siau K. COVID-19 in gastroenterology: Where are we now? Current evidence on the impact of COVID-19 in gastroenterology. United European Gastroenterol J 2021. [PMID: 34190413 DOI: 10.1002/ueg2.12115] [Reference Citation Analysis]
118 Kuramitsu K, Yamanaga S, Osawa R, Hibi T, Yoshikawa M, Toyoda M, Shimata K, Yosuke E, Ono M, Kenmochi T, Sogawa H, Natori Y, Yano H, Chen-Yoshikawa T, Yoshida K, Fukumoto T, Yuzawa K, Egawa H. Impact of COVID-19 on the Living Donor Liver and Kidney Transplantation Programs in Japan in 2020. Transpl Infect Dis 2022. [PMID: 35505462 DOI: 10.1111/tid.13845] [Reference Citation Analysis]
119 Efe C, Dhanasekaran R, Lammert C, Ebik B, Higuera-de la Tijera F, Aloman C, Rıza Calışkan A, Peralta M, Gerussi A, Massoumi H, Catana AM, Torgutalp M, Purnak T, Rigamonti C, Gomez Aldana AJ, Khakoo N, Kacmaz H, Nazal L, Frager S, Demir N, Irak K, Ellik ZM, Balaban Y, Atay K, Eren F, Cristoferi L, Batıbay E, Urzua Á, Snijders R, Kıyıcı M, Akyıldız M, Ekin N, Carr RM, Harputluoğlu M, Hatemi I, Mendizabal M, Silva M, Idilman R, Silveira M, Drenth JPH, Assis DN, Björnsson E, Boyer JL, Invernizzi P, Levy C, Schiano TD, Ridruejo E, Wahlin S. Outcome of COVID-19 in Patients With Autoimmune Hepatitis: An International Multicenter Study. Hepatology 2021;73:2099-109. [PMID: 33713486 DOI: 10.1002/hep.31797] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
120 Cai Y, Ye LP, Song YQ, Mao XL, Wang L, Jiang YZ, Que WT, Li SW. Liver injury in COVID-19: Detection, pathogenesis, and treatment. World J Gastroenterol 2021; 27(22): 3022-3036 [PMID: 34168405 DOI: 10.3748/wjg.v27.i22.3022] [Reference Citation Analysis]
121 Ito T, Kenmochi T, Ota A, Kuramitsu K, Soyama A, Kinoshita O, Eguchi S, Yuzawa K, Egawa H. National survey on deceased donor organ transplantation during the COVID-19 pandemic in Japan. Surg Today 2021. [PMID: 34686930 DOI: 10.1007/s00595-021-02388-1] [Reference Citation Analysis]
122 Shousha HI, Ramadan A, Lithy R, El-Kassas M. Patterns of liver profile disturbance in patients with COVID-19 . World J Clin Cases 2022; 10(7): 2063-2071 [DOI: 10.12998/wjcc.v10.i7.2063] [Reference Citation Analysis]
123 Ng A. Graft injury and re-transplantation in liver transplant patients with COVID-19. Journal of Liver Transplantation 2021;1:100008. [DOI: 10.1016/j.liver.2021.100008] [Reference Citation Analysis]
124 Marjot T, Buescher G, Sebode M, Barnes E, Barritt AS 4th, Armstrong MJ, Baldelli L, Kennedy J, Mercer C, Ozga AK, Casar C, Schramm C;  contributing Members and Collaborators of ERN RARE-LIVER/COVID-Hep/SECURE-Cirrhosis; Moon AM, Webb GJ, Lohse AW. SARS-CoV-2 infection in patients with autoimmune hepatitis. J Hepatol. 2021;74:1335-1343. [PMID: 33508378 DOI: 10.1016/j.jhep.2021.01.021] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 17.0] [Reference Citation Analysis]
125 Ng A. Liver Injury in Liver Transplant Patients With COVID-19: A Histopathologic Analysis. Clin Gastroenterol Hepatol 2021;19:1508-9. [PMID: 33581360 DOI: 10.1016/j.cgh.2021.02.016] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
126 Becchetti C, Gschwend SG, Dufour JF, Banz V. COVID-19 in Liver Transplant Recipients: A Systematic Review. J Clin Med 2021;10:4015. [PMID: 34501463 DOI: 10.3390/jcm10174015] [Reference Citation Analysis]